Poseida Therapeutics Downgraded to Neutral From Overweight at Cantor Fitzgerald

Yahoo Finance4minutes ago

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga16:06 ET

Poseida Therapeutics Cut to Market Perform From Outperform by William Blair

Dow Jones11:24 ET · Ratings

Why This Gene-Therapy Company's Stock Is Rising 228% -- Barrons.com

Barron's11:10 ET

Poseida Therapeutics Up Nearly 225%, On Pace For Record High Close -- Data Talk

Dow JonesNov 26 10:03 ET

US Stocks Mixed; Best Buy Posts Downbeat Earnings

BenzingaNov 26 09:48 ET